• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    MIRA`s Mira-55 Avoids THC, Rimonabant CNS Side Effects

    PHARMIWEB

    MIRA Pharma Progresses Ketamir-2 To Phase 1 MAD Study

    INDPHARMAPOST

    MIRA Starts Ph1 Study of Ketamir-2 for Neuropathic Pain

    PHARMIWEB

    MIRA Pharma Reports Positive PTSD Data For Ketamir-2 In Animals

    PHARMAWEB

    MIRA Pharma Completes Ph 1 of Oral Ketamir-2, No Safety Issues

    PHARMAWEB

    MIRA Pharma Gets FDA Nod for Ketamir-2 IND, Pain Trials

    ACCESSWIRE

    Mira Pharma Highlights SKNY-1 Data for Weight, Smoking Market

    ACCESSWIRE

    MIRA Board Approves $60M SKNY Acquisition Deal

    ACCESSWIRE

    Mira seeks to buy Skny for obesity, smoking cessation asset

    FIERCE BIOTECH

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.